Integra LifeSciences Cor... (IART)
NASDAQ: IART
· Real-Time Price · USD
14.13
0.51 (3.74%)
At close: Aug 15, 2025, 2:57 PM
Integra LifeSciences Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 217.91M | 239.1M | 246.38M | 215.16M | 215.24M | 591.91M | 276.4M | 273.73M | 309.19M | 307.37M | 456.66M | 511.94M | 447.15M | 407.09M | 513.45M | 470.23M | 397.41M | 408.98M |
Short-Term Investments | 35.69M | 34.19M | 27.19M | 62.44M | 81.69M | 71.19M | 32.69M | 19.94M | 20.2M | 15.66M | 16.68M | 13.11M | 4.37M | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | 46.01M | -2.56B | 32.18M | 52.46M | 40.92M | 31.8M | 567.34M | 566.61M | 565.88M | 19.35M | 564.43M | 19.27M | 10.03M | 656K |
Other Long-Term Assets | 46.24M | 53.2M | 66.52M | 54.01M | 24.81M | 2.63B | 26.01M | 25.45M | 26.28M | 24.38M | -510.15M | -488.71M | -517.66M | 10.17M | -547.99M | 10.22M | 10.84M | 36.08M |
Receivables | 284.51M | 252.45M | 272.37M | 248.3M | 277.78M | 241.09M | 259.33M | 256.27M | 258.66M | 264.06M | 263.46M | 248.27M | 237.36M | 234.01M | 231.83M | 222.23M | 229.82M | 223.54M |
Inventory | 465.13M | 445.42M | 429.09M | 436.93M | 421.77M | 403.42M | 389.61M | 366.25M | 354.29M | 351.27M | 324.58M | 311.06M | 320.21M | 328M | 317.39M | 327.17M | 323.62M | 328.05M |
Other Current Assets | 36.12M | 32.21M | 29.65M | 50.37M | 22.17M | 35.37M | 32.64M | 130.98M | 129.11M | 106.78M | 31.03M | 1.83M | 30.52M | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 1.14B | 1.11B | 1.08B | 1.1B | 1.11B | 1.42B | 1.06B | 1.03B | 1.05B | 1.03B | 1.16B | 1.2B | 1.14B | 1.07B | 1.15B | 1.1B | 1.03B | 1.04B |
Property-Plant & Equipment | 571.39M | 561.38M | 549.76M | 537.25M | 521.04M | 497.19M | 496.38M | 475.48M | 466.22M | 461.69M | 459.59M | 449M | 447.56M | 390.85M | 396.25M | 381.52M | 384.93M | 387.37M |
Goodwill & Intangibles | 1.8B | 2.29B | 2.3B | 2.33B | 2.32B | 2.06B | 2.12B | 2.1B | 2.14B | 2.15B | 2.17B | 2.03B | 2.07B | 2.13B | 2.16B | 2.17B | 2.19B | 2.2B |
Total Long-Term Assets | 2.53B | 2.95B | 2.96B | 2.97B | 2.96B | 2.66B | 2.72B | 2.71B | 2.73B | 2.71B | 2.73B | 2.61B | 2.62B | 2.61B | 2.63B | 2.67B | 2.68B | 2.7B |
Total Assets | 3.67B | 4.05B | 4.04B | 4.07B | 4.07B | 4.08B | 3.78B | 3.74B | 3.78B | 3.74B | 3.89B | 3.81B | 3.75B | 3.67B | 3.78B | 3.77B | 3.71B | 3.74B |
Account Payables | 92.83M | 91.3M | 82.5M | 77.67M | 107.49M | 94.4M | 92.33M | 93.55M | 99.77M | 112.78M | 102.1M | 80.73M | 69.5M | 88.37M | 61.84M | 59.6M | 65.51M | 61.5M |
Deferred Revenue | 11.1M | 10.54M | 10.48M | 9.99M | 9.9M | 7.84M | 8.54M | 8.14M | 8.28M | 7.74M | 7.25M | 6.36M | 5.42M | 5.34M | 5.29M | 5.39M | 5.89M | 5.4M |
Short-Term Debt | 613.38M | 612.65M | 607.08M | 601.5M | 38.83M | 35.68M | 14.53M | 86.05M | 95.64M | n/a | 52.75M | 69.74M | 63.37M | 59.3M | 59.77M | 58.53M | 58.99M | 155.9M |
Other Current Liabilities | 66.93M | 52.38M | 85.62M | 131.94M | 87.87M | 95.59M | 100.84M | 97.78M | 64.64M | 93.36M | 65.41M | 65.5M | 74.96M | 91.04M | 105.68M | 116.59M | 102.33M | 65.44M |
Total Current Liabilities | 929.81M | 918.45M | 922.13M | 912.56M | 328.32M | 302.39M | 306.98M | 355.71M | 377.5M | 282.29M | 320.91M | 304.45M | 295.6M | 315.83M | 340.02M | 332.86M | 318.76M | 412.3M |
Long-Term Debt | 1.23B | 1.23B | 1.2B | 1.21B | 1.8B | 1.34B | 1.49B | 1.42B | 1.33B | 1.44B | 1.41B | 1.49B | 1.5B | 1.5B | 1.5B | 1.5B | 1.5B | 1.48B |
Other Long-Term Liabilities | 253.16M | 160.46M | 146.24M | 181.71M | 154.82M | 635.25M | 192.24M | 142.35M | 153.34M | 126.85M | 138.5M | 63.73M | 83M | 94.6M | 120.26M | 145.62M | 161.73M | 154.18M |
Total Long-Term Liabilities | 1.7B | 1.61B | 1.57B | 1.63B | 2.21B | 2.18B | 1.89B | 1.8B | 1.72B | 1.79B | 1.76B | 1.78B | 1.8B | 1.74B | 1.76B | 1.81B | 1.82B | 1.8B |
Total Liabilities | 2.63B | 2.53B | 2.49B | 2.54B | 2.54B | 2.48B | 2.19B | 2.16B | 2.09B | 2.07B | 2.09B | 2.08B | 2.09B | 2.06B | 2.1B | 2.14B | 2.14B | 2.21B |
Total Debt | 2.01B | 2.02B | 1.98B | 1.99B | 2.01B | 186.38M | 1.68B | 1.04B | 1.6B | 940.85M | 1.62B | 1.71B | 1.72B | 1.65B | 1.65B | 1.65B | 1.65B | 1.75B |
Common Stock | 923K | 921K | 916K | 916K | 916K | 915K | 909K | 909K | 909K | 908K | 905K | 903K | 903K | 900K | 896K | 896K | 895K | 894K |
Retained Earnings | 430.55M | 914.62M | 939.91M | 920.48M | 931.18M | 943.58M | 946.86M | 927.02M | 907.53M | 903.34M | 879.12M | 826.17M | 776.26M | 731.47M | 698.57M | 653.18M | 609.96M | 574.89M |
Comprehensive Income | -30.91M | -24.11M | -27.57M | -24.85M | -18.73M | -10.65M | -15.11M | 1.75M | 4.83M | 7.07M | 10.27M | -7.44M | -13.21M | -21.02M | -45.16M | -46.77M | -49.96M | -43.63M |
Shareholders Equity | 1.04B | 1.52B | 1.55B | 1.52B | 1.53B | 2.9B | 1.59B | 1.58B | 1.68B | 1.67B | 1.8B | 1.72B | 1.66B | 1.62B | 1.68B | 1.63B | 1.57B | 1.53B |
Total Investments | 35.69M | 34.19M | 27.19M | 62.44M | 127.7M | 71.19M | 64.87M | 52.46M | 40.92M | 31.8M | 567.34M | 566.61M | 565.88M | 19.35M | 564.43M | 19.27M | 10.03M | 656K |